Vaccines
Overview
Vaccines split into two categories that drive every contraindication decision. Live attenuated vaccines contain weakened but replicating organisms, so they are restricted in immunocompromised and pregnant patients. Inactivated (killed or subunit) vaccines cannot replicate and are safe regardless of immune status. The route can signal the type: intranasal influenza is live, while the injectable form is inactivated.
Live attenuated vs inactivated
Live attenuated
- Examples
- MMR, varicella, rotavirus, intranasal influenza (LAIV), oral polio
- Mechanism
- Weakened organism replicates in host
- Key contraindication
- Immunocompromise and pregnancy
- Immunocompromised patient
- Defer until immune recovery
Inactivated
- Examples
- DTaP, IPV, Hep B, Hep A, PCV13, injectable (IM) influenza
- Mechanism
- No live organism; cannot cause infection
- Key contraindication
- Few (anaphylaxis to dose/component)
- Immunocompromised patient
- Safe and recommended
Overview — Giving Vaccines
Pediatric vaccine administration pairs correct site and technique with caregiver teaching. Site is chosen by age: vastus lateralis for infants under 12 months, deltoid acceptable after age 3. Multiple vaccines can be given at one visit using separate syringes and separate sites. Federal law requires the Vaccine Information Statement (VIS) before every dose.
Overview — Immunization Basics
Vaccines trigger active immunity — the body builds its own antibody memory. Live attenuated vaccines (MMR, varicella, rotavirus, intranasal flu) contain weakened organisms that replicate briefly; inactivated vaccines (DTaP, IPV, hepatitis B, pneumococcal) use killed organisms or subunits and need multiple doses.
Interpretation
Distinguish a true contraindication (vaccine permanently or currently withheld) from a precaution (defer, then give once resolved) and from a false contraindication (no reason to delay).
Interpretation — Giving Vaccines
Injection site and route are dictated by age and vaccine type. The dorsogluteal site is contraindicated at every age due to sciatic nerve proximity.
IM injection site by age
Age
- Infant <12 mo
- Vastus lateralis
- After 12 mo (walking)
- Vastus lateralis
- After age 3
- Deltoid acceptable
Preferred site
- Infant <12 mo
- Anterolateral thigh
- After 12 mo (walking)
- Anterolateral thigh
- After age 3
- Upper arm
Why
- Infant <12 mo
- Deltoid muscle mass insufficient
- After 12 mo (walking)
- Greatest muscle mass until deltoid is adequate
- After age 3
- Sufficient deltoid mass
Interpretation — Immunization Basics
Technique
Vaccine administration sequence
- Verify ordercheck expiration
- Provide VISbefore any dose
- Screen allergiescontraindications
- Select site + prepareage-based
- Administercorrect angle/depth
- Documentsite, route, lot #
- Observe 15-30 minanaphylaxis watch
During — Monitoring
Scheduling and spacing rules for combined visits.
After — Complications
Distinguish a normal post-vaccine response from a reportable adverse reaction. Expected reactions are managed at home; reportable reactions require clinical action and VAERS reporting.
Schedule
Patient Teaching
Reassure families about findings that are NOT reasons to withhold a vaccine (false contraindications).
Patient Teaching — Giving Vaccines
Patient Teaching — Immunization Basics
Clinical Pearl
Live vaccines LIVE in you — they replicate, so if it replicates, it's restricted (never in immunocompromise or pregnancy).